Michael Erickson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Erickson
Michael Erickson is recorded as CEO at Idexx Laboratories Inc /De (IDXX). Idexx Laboratories Inc /De reported in an 8-K filed January 13, 2026 that Michael Erickson was appointed President and Chief Executive Officer, effective May 12, 2026. Michael Erickson has spoken on 1 earnings call across 1 company, most recently for Idexx Laboratories Inc /De on May 5, 2026.
“This Agreement amends and restates in its entirety the Change in Control Agreement by and between the Company and the Executive dated as of August 2, 2024 and will become effective upon the assumption by Executive of the role of President and Chief Executive Officer, which is currently expected to occur on May 12, 2026 (the "Agreement Date"), subject to the Executive's continued employment with the Company through the Agreement Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Idexx Laboratories Inc /De (IDXX)
Proxy statement
Start not stated–2025-03-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Idexx Laboratories Inc /De
Other people whose current roles at this company are on record from its filings.
- Jonathan Mazelsky CEO
- Michael (Mike) Erickson CEO, Board Member
- Michael (Mike) Erickson, PhD CEO, Board Member
- Jonathan (Jay) Mazelsky Chairman
- Lawrence D. Kingsley Chairman
- Andrew Emerson CFO
- Brian McKeon CFO
- Martin Smith CTO
- Sharon E. Underberg General Counsel
- Asha S. Collins, PhD Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.